Teril and Yusimry drug interactions - a phase IV clinical study of FDA data
We study 13 people who take Teril or Yusimry. There is no drug interaction reported.
The phase IV clinical study analyzes what interactions people who take Teril and Yusimry have. It is created by eHealthMe based on reports the from the FDA, and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
No report is found.
What is Teril?
Teril has active ingredients of carbamazepine. eHealthMe is studying from 13 Teril users for its effectiveness, alternative drugs and more.
What is Yusimry?
Yusimry has active ingredients of adalimumab-aqvh.
Do you take Teril and Yusimry?Personalize this study to your gender and age
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Puvanendran R, Teo HZ, "Case report of use of Black Cohosh for carbamazepine induced hot flushes in a post menopausal woman", Maturitas, 2017 Jun .
- Arshad F, Ladakhi Y, Khan MA, "A rare case of carbamazepine induced pancreatitis", International Journal of Students’ Research, 2013 Jul .
- Yava?o?lu I, Sarg?n G, Demirbulat A, "Carbamazepine and hematological malignancies", Turkish journal of haematology: official journal of Turkish Society of Haematology, 2013 Jan .
Alternative drugs to, pros and cons of the 2 drugs:
How the study uses the data?
The study uses data from the FDA. It is based on carbamazepine and adalimumab-aqvh (the active ingredients of Teril and Yusimry, respectively), and Teril and Yusimry (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Teril and Yusimry.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Benadryl vs. Ipratropium Bromide - 8 seconds ago
- Latuda and Psychotic Behavior - 15 seconds ago
- Adcirca and Oesophageal Varices Haemorrhage - 16 seconds ago
- Lower Urinary Tract Symptoms and Abdominal Pain - 18 seconds ago
- Percocet vs. Doxylamine Succinate - 27 seconds ago
- Benadryl and Colitis Ulcerative Aggravated - 29 seconds ago
- Rocaltrol and Haemorrhagic Erosive Gastritis - 32 seconds ago
- Intuniv and Delirium - 35 seconds ago
- Enzalutamide and Guillain-Barre Syndrome - 35 seconds ago
- Enzalutamide and Guillain Barre Syndrome - 35 seconds ago